These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 13327547)

  • 41. [EFFECT OF CALCIUM, IONIC STRENGTH AND TEMPERATURE ON THE ENZYMATIC PHASE OF FIBRINOGEN CONVERSION TO FIBRIN].
    GRIAZNUKHINA EA
    Ukr Biokhim Zh; 1964; 36():898-906. PubMed ID: 14298739
    [No Abstract]   [Full Text] [Related]  

  • 42. [Plasma fibrinogen in multiple sclerosis].
    PERSSON I
    Nord Med; 1952 Mar; 47(10):310-2. PubMed ID: 14911005
    [No Abstract]   [Full Text] [Related]  

  • 43. [IMPORTANCE OF BLOOD LEVELS OF FIBRIN IN THE INTERPRETATION OF THE MAXIMUM AMPLITUDE OF THROMBODYNOGRAMS].
    SAMAMA M; PROST RJ; MARCHAL G
    Hemostase; 1963; 3():165-76. PubMed ID: 14050813
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of protamine on fibrinogen in vivo and in vitro].
    WITTE S; DIRNBERGER P
    Klin Wochenschr; 1952 Nov; 30(41-2):997. PubMed ID: 13023943
    [No Abstract]   [Full Text] [Related]  

  • 45. [Plasma fibrinogen and sedimentation reaction in various diseases].
    HASCHE E
    Nord Med; 1952 Nov; 48(46):1584-5. PubMed ID: 13025906
    [No Abstract]   [Full Text] [Related]  

  • 46. Fibrinolysis and changes in fibrinogen in multiple myeloma.
    SIRRIDGE MS; BOWMAN KS; GARBER PE
    AMA Arch Intern Med; 1958 Mar; 101(3):630-5. PubMed ID: 13507745
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fibrinolysis in blood diseases of children].
    PASSARO G; GRASSINI A
    Arch Ital Pediatr Pueric; 1955; 17(6):504-30. PubMed ID: 13303731
    [No Abstract]   [Full Text] [Related]  

  • 48. The turnover rate of fibrinogen in the dog.
    MADDEN RE; GOULD RG
    J Biol Chem; 1952 May; 196(2):641-50. PubMed ID: 12981007
    [No Abstract]   [Full Text] [Related]  

  • 49. ON THE GRAVIMETRIC ESTIMATION OF FIBRINOGEN IN PLASMA.
    PERSSON I
    Scand J Clin Lab Invest; 1963; 15():353-6. PubMed ID: 14073283
    [No Abstract]   [Full Text] [Related]  

  • 50. [Complications due to fibrinolysis and fibrinogenolysis in surgical and obstetrical cases].
    BLOMBACK B; BLOMBACK M; SENNING A; WALLEN P
    Nord Med; 1955 Jun; 53(26):1019-24. PubMed ID: 13244877
    [No Abstract]   [Full Text] [Related]  

  • 51. CLINICAL ANESTHESIA CONFERENCE.
    MARK LC; MARX GF; HENRY EL; KEPES ER; MAZZA L; TIERS FM
    N Y State J Med; 1964 Jul; 64():1860-2. PubMed ID: 14154608
    [No Abstract]   [Full Text] [Related]  

  • 52. ["Fetal fibrinogen"].
    KUENZER W
    Klin Wochenschr; 1961 May; 39():536-7. PubMed ID: 13754910
    [No Abstract]   [Full Text] [Related]  

  • 53. [Marked fibrinolysis and fibrinogenelysis as possible pathogenetic consequences of immunitary phenomena in the organism].
    ZARDI O
    Rend Ist Sup Sanit; 1956; 19(4-5):437-48. PubMed ID: 13350604
    [No Abstract]   [Full Text] [Related]  

  • 54. [Biological investigations on gelatinolytic, fibrinolytic, antidottic diastases, present in culture filtrates of certain germs. II].
    Richou R; Kourilsky R
    Rev Immunol Ther Antimicrob; 1955; 19(5-6):361-86. PubMed ID: 13323661
    [No Abstract]   [Full Text] [Related]  

  • 55. Action of fibrinolysin (plasmin) on proteins.
    KAPLAN EH
    Proc Soc Exp Biol Med; 1954 Jan; 85(1):142-4. PubMed ID: 13134315
    [No Abstract]   [Full Text] [Related]  

  • 56. [A new inhibitor of thromboplastin generation produced during the proteolytic degradation of fibrinogen].
    NIEWIAROWSKI S; LATALLO Z; STACHURSKA J
    Sangre (Barc); 1959; 30():376-8. PubMed ID: 14427140
    [No Abstract]   [Full Text] [Related]  

  • 57. Critical evaluation of the fibrin plate method for estimating fibrinolytic enzymes and activators.
    AUERSWALD W; DOLESCHEL W
    Thromb Diath Haemorrh; 1960 Oct; 5():112-20. PubMed ID: 13685088
    [No Abstract]   [Full Text] [Related]  

  • 58. The proteolytic action of thrombin on fibrinogen.
    DONNELLY TH; LASKOWSKI M; SCHERAGA HA; VAN TIJN BA
    J Biol Chem; 1956 Oct; 222(2):815-21. PubMed ID: 13367049
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the activating factors in fibrinolytic system. II. Streptococcal and staphylococcal fibrinolysis.
    HAYASHI T; MAEKAWA S
    Jpn J Exp Med; 1954 Oct; 24(5):287-305. PubMed ID: 13242259
    [No Abstract]   [Full Text] [Related]  

  • 60. [THE PLASMATIC FACTOR OF THE SURFACE COAGULATIVE ACTIVITY OF STAPHYLOCOCCUS].
    GELOSA L
    Boll Ist Sieroter Milan; 1964; 43():188-96. PubMed ID: 14168463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.